Amphotericin B Liposome is an antifungal medication used for the treatment of serious fungal infections. It is a single-dose vial containing 50 mg of the medication. Amphotericin B Liposome works by disrupting the fungal cell membrane, killing the fungus and stopping its growth. It is typically only used for severe or life-threatening infections, and is administered intravenously by a healthcare professional. It may have potential side effects, such as fever, chills, nausea, and kidney damage, so it should only be used under medical supervision.
Amphotericin B Liposome is an injectable medication used to treat fungal infections. It is provided in single-dose vials containing 50 mg of the medication.
Advanced Antifungal Protection: Amphotericin B Liposome 50 mg by Eugia
Tackle severe, life-threatening fungal infections in clinical settings with Amphotericin B Liposome 50 mg Single-Dose Vial by Eugia (NDC: 55150-0365-01). This hospital-grade, liposomal encapsulated amphotericin B delivers potent broad-spectrum activity while significantly reducing the risk of kidney toxicity and infusion reactions compared to conventional amphotericin B formulations. Eugia’s commitment to pharmaceutical excellence ensures every vial delivers consistent, reliable performance for your most vulnerable patients.
Uses
-
Empiric Therapy for Febrile Neutropenia: First-line option for suspected invasive fungal infections in immunocompromised patients.
-
Confirmed Severe Mycoses: Treats systemic infections such as invasive aspergillosis, cryptococcal meningitis in HIV patients, candidiasis, histoplasmosis, blastomycosis, and mucormycosis.
-
Visceral Leishmaniasis: Effective for this parasitic infection, as per clinical protocol.
Benefits
-
Broad-Spectrum Efficacy: Active against a wide range of pathogenic fungi and molds.
-
Reduced Nephrotoxicity: Liposomal delivery minimizes renal damage and adverse effects, making it a safer option for high-risk patients.
-
Lower Infusion-Related Reactions: Improved patient tolerance compared to standard amphotericin B therapy.
-
Hospital-Trusted: Ideal for use in critical care, oncology, transplant, and infectious disease units.
-
Single-Dose Flexibility: Each 50 mg vial supports accurate, tailored dosing with minimal waste.
-
Eugia Quality Assurance: Manufactured to stringent standards for sterility, potency, and safety.
Specifications
| Feature |
Detail |
| Product Name |
Amphotericin B Liposome |
| Strength |
50 mg per vial (lyophilized powder) |
| Packaging |
Single-dose vial |
| NDC |
55150-0365-01 |
| Manufacturer |
Eugia US LLC |
| Route |
Intravenous (IV) infusion after reconstitution |
| Formulation |
Lyophilized sterile powder |
| Prescription |
Rx Only |
Â
Directions
For use under the supervision of qualified healthcare professionals only.
-
Preparation:
- Reconstitute each vial with 12 mL Sterile Water for Injection (do NOT use saline or bacteriostatic water).
- Gently swirl (do not shake) until fully dissolved.
- Further dilute the reconstituted solution in 5% Dextrose Injection (D5W).
-
Administration:
- Infuse intravenously over approximately 2 hours.
- Usual adult dose: 3–5 mg/kg once daily for invasive fungal infections, adjusted per infection type, patient factors, and clinical response.
- Always follow hospital, manufacturer, and clinical guidelines for exact dosing and infusion rates.
- Do not mix with sodium chloride solution or combine with other drugs.
- Monitor closely during infusion for hypersensitivity or infusion-related reactions.
Side Effects
Common Side Effects:
- Chills, fever, back pain, headache during infusion
- Nausea, vomiting
- Low potassium or magnesium (electrolyte disturbances)
- Mild, reversible kidney function changes
Serious/Rare Side Effects:
- Severe infusion-related reactions (hypotension, chest pain, breathing difficulty)
- Anaphylactic shock
- Nephrotoxicity (rare, but possible)
- Severe electrolyte imbalances
- Liver toxicity
Notify medical staff immediately with signs of allergic reaction, severe shortness of breath, chest pain, or decreased urination.
Warnings
-
Prescription Hospital Use Only: To be reconstituted, diluted, and administered by trained medical professionals in an inpatient setting.
-
Monitor Renal and Hepatic Function: Regular lab checks for serum creatinine, electrolytes (especially potassium and magnesium), and liver enzymes are required.
-
Do Not Mix with Saline or Other Medications: Only use 5% dextrose for dilution and infusion.
-
Pregnancy & Pediatrics: Use only if benefits outweigh risks; closely monitor pregnant women, children, and frail or elderly patients.
-
Infusion Reactions: Premedicate or slow the infusion if patients have a history of infusion reactions or experience significant symptoms.
Why Choose Amphotericin B Liposome 50 mg by Eugia?
Amphotericin B Liposome 50 mg (NDC: 55150-0365-01) by Eugia combines the antifungal gold standard with the benefits of advanced liposomal delivery. For hospitals, infusion centers, and clinics demanding effective, patient-friendly, and safer antifungal care, Eugia’s solution delivers confidence, consistency, and results.
Order Amphotericin B Liposome 50 mg Single-Dose Vial by Eugia for advanced, low-toxicity treatment of invasive fungal infections.
Â